Gynecologic Oncology最新收录文章列表-丁香通

简称Gynecol Oncol

大类医学

小类妇产科学、肿瘤学

ISSN0090-8258

EISSN1095-6859

最新文献

Expression of antibody drug conjugate target antigens in ovarian sex cord stromal Tumors

PMID: 415765502026-02

Feasibility IB trial of paclitaxel/carboplatin + Galunisertib. (a small molecule inhibitor of the kinase domain of type 1 TGF-B receptor) in patients with newly diagnosed, persistent or recurrent carcinosarcoma of the uterus or ovary

PMID: 411972292025-12

Postmenopausal bleeding: Association of initial place of care with stage at diagnosis for uterine cancer

PMID: 411669842025-10-29

Racial/ethnic disparities in time from diagnosis to surgical treatment for type I and type II endometrial carcinomas

PMID: 406390632025-08

A randomized pilot study of HPV16 L2E7E6 fusion protein vaccination site post-treatment for HPV16+ cervical cancer

PMID: 408399572025-08

Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysis

PMID: 404826072025-07

Pathogenic germline variants among women with uterine cancer by ancestry: A commercial laboratory collaborative research registry study

PMID: 403004262025-06

Influence of residential segregation and health provider density on advanced stage endometrial cancer diagnoses

PMID: 401795182025-05

Three-dimensional volumetric rendering on augmented reality headsets for ovarian cancer cytoreduction planning: A Memorial Sloan Kettering Cancer Center Team Ovary study

PMID: 401870232025-05

A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: An NRG oncology/GOG study

PMID: 400568322025-04

Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody-drug conjugate

PMID: 401219722025-04

Anaplastic carcinoma of the ovary: A single-institution experience and molecular analysis

PMID: 401126662025-04

Incorporation of triapine (T) to cisplatin chemoradiation (CRT) for locally advanced cervical and vaginal cancer: Results from NRG-GY006, a phase III randomized trial

PMID: 401016062025-04

The genomic landscape of distant metastatic endometrial cancer

PMID: 400811122025-04

Evaluation of efficacy and fertility after nonradical surgical therapy (extra fascial hysterectomy or cone biopsy, with pelvic lymphadenectomy) for stage IA1, IA2, and IB1 cervical cancer (GOG-0278)

PMID: 400568312025-04

Evaluation of physical function and quality of life before and after nonradical surgical therapy for stage IA1 and IA2-IB1 cervical cancer (GOG-0278)

PMID: 400581842025-04

Ultrasound-based versus immediate biopsy-based management of postmenopausal bleeding in non-Hispanic Black and non-Hispanic White individuals

PMID: 399858692025-03

A clinical study of tremelimumab, alone or in combination with olaparib, for recurrent epithelial ovarian cancer

PMID: 399519182025-03

Molecular classification of endometrial cancers (EC) and association with relapse-free survival (RFS) and overall survival (OS) outcomes: Ancillary analysis of GOG-0258

PMID: 398548062025-02

Prognostic significance of serum complement activation, neutrophil extracellular traps and extracellular DNA in newly diagnosed epithelial ovarian cancer

PMID: 397648572025-02

大家都在搜